Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,280 | 13,650 | 1,240 | 3,860 | 11,640 |
| Marketable Securities | 25,240 | 25,370 | 17,690 | 17,070 | 11,210 |
| Other current assets | 390 | 640 | 50 | 100 | 180 |
| TOTAL | $35,910 | $39,660 | $18,980 | $21,030 | $23,030 |
| Non-Current Assets | |||||
| PPE Net | 920 | 920 | 900 | N/A | N/A |
| Other Non-Current Assets | 1,130 | 1,150 | 1,160 | 1,210 | 1,180 |
| TOTAL | $2,050 | $2,070 | $2,060 | $1,210 | $1,180 |
| Total Assets | $37,090 | $40,880 | $20,200 | $22,280 | $24,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,040 | 1,430 | 1,540 | 930 | 0 |
| Accrued Expenses | 2,090 | 2,140 | 2,030 | 1,490 | 1,710 |
| Other current liabilities | 0 | 150 | 150 | 730 | 1,290 |
| TOTAL | $3,130 | $3,740 | $3,730 | $3,300 | $3,000 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $440 | $N/A |
| Total Liabilities | $3,130 | $3,740 | $3,730 | $3,750 | $3,000 |
| Shareholders' Equity | |||||
| Common Shares | 160 | 160 | 140 | 140 | 140 |
| Retained earnings | -84,880 | -82,080 | -80,020 | -78,330 | -74,970 |
| Other shareholders' equity | -890 | -550 | -1,320 | -1,410 | -1,330 |
| TOTAL | $33,950 | $37,130 | $16,470 | $18,520 | $21,440 |
| Total Liabilities And Equity | $37,080 | $40,870 | $20,200 | $22,270 | $24,440 |